Improving pregnancy drug warnings to promote patient comprehension.
Am J Obstet Gynecol
; 204(4): 318.e1-5, 2011 Apr.
Article
en En
| MEDLINE
| ID: mdl-21316641
OBJECTIVE: We sought to evaluate the effectiveness of a pharmaceutical labeling strategy intended to improve comprehension of a teratogen warning. STUDY DESIGN: This is a secondary analysis that evaluated women of childbearing age who were assigned prescription containers with the current teratogen warning, a label with simplified text, or a label with simplified text and icons. The association between label type and understanding of label instructions was assessed. RESULTS: A total of 132 women were interviewed. Comprehension of the icon label (94%) was higher than for the standard and enhanced text-only labels (76% and 79%), respectively (P < .05). Adjustment for age, race/ethnicity, education, literacy, and number of current medications revealed that the label with the enhanced text and icon yielded superior comprehension (risk ratio vs standard, 1.26; 95% confidence interval, 1.04-1.53; risk ratio vs enhanced, 1.22; 95% confidence interval, 1.02-1.46). CONCLUSION: In our study, a teratogen warning label that had easy-to-read messages with icons significantly improved comprehension.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Teratógenos
/
Comprensión
/
Etiquetado de Medicamentos
/
Medicamentos bajo Prescripción
Tipo de estudio:
Clinical_trials
Límite:
Adult
/
Female
/
Humans
/
Pregnancy
Idioma:
En
Revista:
Am J Obstet Gynecol
Año:
2011
Tipo del documento:
Article
País de afiliación:
Estados Unidos
Pais de publicación:
Estados Unidos